logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11793882 B1

PDFFull Text
Date of Patent:
Oct. 24, 2023

Filed:

Dec. 20, 2019

Glycotargeting therapeutics

Applicant:

École Polytechnique Fédérale DE Lausanne (Epfl), Lausanne, CH;

Inventors:

Jeffrey A Hubbell, Chicago, IL (US);

David Scott Wilson, Lausanne, CH;

Assignee:

ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL), Lausanne, CH;

Attorney:

Knobbe, Martens, Olson & Bear LLP

Primary Examiner:

Thea D' Ambrosio

Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/385 (2006.01); A61K 47/64 (2017.01); C07K 16/28 (2006.01); C07K 16/24 (2006.01); A61K 38/20 (2006.01); A61K 38/37 (2006.01); A61K 38/08 (2019.01); A61K 38/28 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/38 (2006.01); A61K 39/35 (2006.01); C07K 14/07 (2006.01); A61K 47/54 (2017.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 38/08 (2013.01); A61K 38/164 (2013.01); A61K 38/1709 (2013.01); A61K 38/2013 (2013.01); A61K 38/28 (2013.01); A61K 38/37 (2013.01); A61K 38/38 (2013.01); A61K 39/001 (2013.01); A61K 39/0002 (2013.01); A61K 39/0005 (2013.01); A61K 39/0008 (2013.01); A61K 39/35 (2013.01); A61K 47/549 (2017.08); C07K 14/07 (2013.01); C07K 16/241 (2013.01); C07K 16/2848 (2013.01); A61K 38/00 (2013.01); A61K 2039/577 (2013.01); A61K 2039/60 (2013.01); A61K 2039/6087 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/55 (2013.01); C07K 2319/01 (2013.01);
Abstract

Several embodiments of the present disclosure relate to glycotargeting therapeutics that are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.

Find Patent Forward Citations

Quick Actions:

Hubbell, Jeffrey. (2023). Glycotargeting therapeutics (U.S. Patent No. 11793882). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11793882

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…